Back to Search Start Over

The chromosome 21 kinase DYRK1A: emerging roles in cancer biology and potential as a therapeutic target.

Authors :
Rammohan M
Harris E
Bhansali RS
Zhao E
Li LS
Crispino JD
Source :
Oncogene [Oncogene] 2022 Apr; Vol. 41 (14), pp. 2003-2011. Date of Electronic Publication: 2022 Feb 26.
Publication Year :
2022

Abstract

Dual-specificity tyrosine phosphorylation-regulated kinase 1 A (DYRK1A) is a serine/threonine kinase that belongs to the DYRK family of proteins, a subgroup of the evolutionarily conserved CMGC protein kinase superfamily. Due to its localization on chromosome 21, the biological significance of DYRK1A was initially characterized in the pathogenesis of Down syndrome (DS) and related neurodegenerative diseases. However, increasing evidence has demonstrated a prominent role in cancer through its ability to regulate biologic processes including cell cycle progression, DNA damage repair, transcription, ubiquitination, tyrosine kinase activity, and cancer stem cell maintenance. DYRK1A has been identified as both an oncogene and tumor suppressor in different models, underscoring the importance of cellular context in its function. Here, we review mechanistic contributions of DYRK1A to cancer biology and its role as a potential therapeutic target.<br /> (© 2022. The Author(s), under exclusive licence to Springer Nature Limited.)

Details

Language :
English
ISSN :
1476-5594
Volume :
41
Issue :
14
Database :
MEDLINE
Journal :
Oncogene
Publication Type :
Academic Journal
Accession number :
35220406
Full Text :
https://doi.org/10.1038/s41388-022-02245-6